Multifunctional small-molecule theranostic agents for tumor-specific imaging and targeted chemotherapy

Area of Science:

• Oncology
• Nanomedicine
• Medicinal Chemistry

Background:

• Cancer remains a leading global cause of mortality, necessitating advanced therapeutic strategies.
• Personalized medicine, tailoring treatments to individual tumor characteristics, improves survival rates and reduces adverse effects.
• Multifunctional theranostic agents integrate diagnostic and therapeutic capabilities into a single platform, enhancing patient compliance and treatment outcomes.

Purpose of the Study:

• To review the design strategies and applications of multifunctional small-molecule theranostic agents.
• To highlight the potential of these agents in tumor-specific imaging and targeted chemotherapy.
• To discuss the challenges and future directions for small-molecule theranostics in personalized cancer therapy.

Main Methods:

• Focus on design principles for creating multifunctional small-molecule theranostic agents.
• Review of in vitro and in vivo studies demonstrating the efficacy of these agents.
• Analysis of current challenges and future research perspectives in the field.

Main Results:

• Multifunctional theranostic agents show significant potential for simultaneous tumor visualization and drug delivery.
• These agents can be designed to target specific tumor characteristics, leading to more precise therapies.
• Integration of diagnostic and therapeutic functions simplifies treatment regimens and improves patient adherence.

Conclusions:

• Multifunctional small-molecule theranostic agents are pivotal in advancing personalized cancer medicine.
• Further research into their design and application will accelerate the development of novel cancer therapies.
• These agents offer a viable strategy to improve treatment efficacy and minimize side effects in oncology.